Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study

Journal:
The Lancet
Published:
DOI:
10.1016/s0140-6736(26)00974-8
Affiliations:
19
Authors:
24
Go to article
Institutions Authors Share
Shanghai Henlius Biotech, Inc., China
6.000000
 0.25
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, China
3.333333
 0.14
Peking University Shenzhen Hospital, China
2.000000
 0.08
Gansu Wuwei Tumor Hospital, China
1.000000
 0.04
The First Hospital of Jilin University, China
1.000000
 0.04
First Hospital of Lanzhou University, LZU, China
1.000000
 0.04
Qinghai University Affiliated Hospital, China
1.000000
 0.04
The Affiliated Hospital of Qingdao University, China
1.000000
 0.04
Gansu Provincial Cancer Hospital / Gansu Provincial Academic Instiute for Medical Research, China
1.000000
 0.04
Xingtai People's Hospital, China
1.000000
 0.04
The First Affiliated Hospital of Xiamen University, China
1.000000
 0.04
Tianjin Medical University Cancer Institute and Hospital, TMU, China
1.000000
 0.04
Peking University People's Hospital, PKUHSC, China
1.000000
 0.04
The First Affiliated Hospital of Henan University of Science and Technology, China
1.000000
 0.04
Liaoning Cancer Hospital and Institute, China
1.000000
 0.04
Inner Mongolia Cancer Hospital, China
0.333333
 0.01
Beijing Cancer Hospital / School of Oncology, PKUHSC, China
0.333333
 0.01